世卫组织-新冠肺炎流行病学更新–2024年5月17日.docxVIP

1

COVID-19EpidemiologicalUpdate

Edition167published17May2024

Inthisedition:

Keyhighlights

?Globaloverview

?HospitalizationsandICUadmissions

?SARS-CoV-2variantsofinterestandvariantsundermonitoring?WHOregionaloverviews

Keyhighlights

?SARS-CoV-2PCRpercentpositivitywas7.3%from79countriesduringtheweekendingon28April2024,asdetectedinintegratedsentinelsurveillanceaspartoftheGlobalInfluenzaSurveillanceandResponseSystem(GISRS)andreportedtoFluNet.

?KP.3andKP.2,bothdescendentlineagesofJN.1andvariantsundermonitoring(VUMs)accountedfor20.0%and9.6%ofsequencesinweek17comparedto3.5%and6.4%inweek14,respectively.Globally,JN.1isthemostreportedvariantofinterest(VOI)(nowreportedby130countries),accountingfor54.3%ofsequencesinweek17andhavingdeclinedfromaprevalenceof69.0%inweek14.TheupdatedriskevaluationforJN.1waspublishedon15April2024,withanoverallevaluationoflowpublichealthriskatthegloballevelbasedonavailableevidence.WHOiscurrentlytrackingseveralSARS-CoV-2variants:fiveVOIs–XBB.1.5,XBB.1.16,EG.5BA.2.86andJN.1;andfourvariantsundermonitoring(VUMs):JN.1.7,JN.1.18,KP.2andKP.3.

?Globally,duringthe28-dayperiodfrom1to28April2024,92countriesreportedCOVID-19casesand35countriesreportedCOVID-19deaths.Notethatthisdoesnotreflecttheactualnumberofcountrieswherecasesordeathsoccur,asmanycountrieshavestoppedorchangedthefrequencyofreporting.

?Fromtheavailabledata,thenumberofreportedcasesanddeathshavedecreasedduringthe28-dayperiod,withover145000newcasesandmorethan2600newdeaths,adecreaseof48%and44%,respectively,comparedtotheprevious28days(4to31March2024).Trendsinthenumberofreportednewcasesanddeathsshouldbeinterpretedwithcautionduetodecreasedtestingandsequencing,alongsidereportingd